相关实验视频

Updated: May 30, 2025

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

对视网膜退行性疾病的光受体替代疗法的进展

Yuxin Du¹, Yin Shen^1,2

¹Eye Center, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, China.

|January 29, 2025

概括

光受体移植为视网膜退行性疾病引起的失明提供了希望. 本综述探讨了供体细胞,整合因子和综合疗法,以改善结果.

科学领域:

眼科和再生医学眼科和再生医学
细胞生物学和移植

背景情况:

视网膜退行性疾病会通过光受体细胞死亡导致视力丧失.
目前针对这些疾病的治疗方法的有效性往往有限.

研究的目的:

审查用于光受体移植的供体细胞来源.
检查影响捐赠细胞集成,成熟和功能的因素.
讨论增强移植疗效的辅助方法.

主要方法:

对光受体移植研究的文献综述.
分析控制捐赠细胞存活和融合的机制.
探索优化以细胞为基础的疗法用于视网膜修复的战略.

主要成果:

有多个供体细胞来源可供移植.
成功的整合和功能取决于特定的生物因素.
组合疗法显示出增强治疗效益的潜力.

结论:

光受体移植是治疗晚期视网膜退行症的一个有希望的策略.
了解供体细胞的行为和优化移植协议至关重要.
对结合方法的进一步研究可能会导致对失明的更有效的治疗方法.

关键词:

基因治疗是一种基因疗法.纳米材料是一种纳米材料.摄影感应器替代体光感受器移植移植视网膜退行性疾病视网膜退行性疾病视网膜炎的颜色素

更多相关视频

Transpupillary-Guided Trans-Scleral Transplantation of Subretinal Grafts in a Retinal Degeneration Mouse Model

Transpupillary-Guided Trans-Scleral Transplantation of Subretinal Grafts in a Retinal Degeneration Mouse Model

Published on: January 26, 2024

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.